Literature DB >> 18792812

GSTpi expression in MPTP-induced dopaminergic neurodegeneration of C57BL/6 mouse midbrain and striatum.

Margarida Castro-Caldas1, Andreia Neves Carvalho, Isabel Peixeiro, Elsa Rodrigues, Maria Celeste Lechner, Maria João Gama.   

Abstract

MPTP-induced dopaminergic neurotoxicity involves major biochemical processes such as oxidative stress and impaired energy metabolism, leading to a significant reduction in the number of nigrostriatal dopaminergic neurons. Glutathione S-transferase pi (GSTpi) is a phase II detoxifying enzyme that provides protection of cells from injury by toxic chemicals and products of oxidative stress. In humans, polymorphisms of GSTP1 affect substrate selectivity and stability increasing the susceptibility to parkinsonism-inducing effects of environmental toxins. Given the ability of MPTP to increase the levels of reactive oxygen species and the link between altered redox potential and the expression and activity of GSTpi, we investigated the effect of MPTP on GSTpi cellular concentration in an in vivo model of Parkinson's disease. The present study demonstrates that GSTpi is actively expressed in both substantia nigra pars compacta and striatum of C57BL/6 mice brain, mostly in oligodendrocytes and astrocytes. After systemic administration of MPTP, GSTpi expression is significantly increased in glial cells in the vicinity of dopaminergic neurons cell bodies and fibers. The results suggest that GSTpi expression may be part of the mechanism underlying the ability of glial cells to elicit protection against the mechanisms involved in MPTP-induced neuronal death.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18792812     DOI: 10.1007/s12031-008-9141-z

Source DB:  PubMed          Journal:  J Mol Neurosci        ISSN: 0895-8696            Impact factor:   3.444


  71 in total

1.  In situ detection of apoptotic nuclei in the substantia nigra compacta of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mice using terminal deoxynucleotidyl transferase labelling and acridine orange staining.

Authors:  N A Tatton; S J Kish
Journal:  Neuroscience       Date:  1997-04       Impact factor: 3.590

2.  Glia cell number modulates sensitivity to MPTP in mice.

Authors:  Michelle Smeyne; Yun Jiao; Kennie R Shepherd; Richard J Smeyne
Journal:  Glia       Date:  2005-11-01       Impact factor: 7.452

3.  Glutathione transferases catalyse the detoxication of oxidized metabolites (o-quinones) of catecholamines and may serve as an antioxidant system preventing degenerative cellular processes.

Authors:  S Baez; J Segura-Aguilar; M Widersten; A S Johansson; B Mannervik
Journal:  Biochem J       Date:  1997-05-15       Impact factor: 3.857

4.  Distribution of mitochondrial manganese superoxide dismutase among rat glial cells in culture.

Authors:  E Pinteaux; M Perraut; G Tholey
Journal:  Glia       Date:  1998-04       Impact factor: 7.452

Review 5.  Oxidative stress and genetics in the pathogenesis of Parkinson's disease.

Authors:  Y Zhang; V L Dawson; T M Dawson
Journal:  Neurobiol Dis       Date:  2000-08       Impact factor: 5.996

6.  Glutathione S-transferase p elicits protection against H2O2-induced cell death via coordinated regulation of stress kinases.

Authors:  Z Yin; V N Ivanov; H Habelhah; K Tew; Z Ronai
Journal:  Cancer Res       Date:  2000-08-01       Impact factor: 12.701

7.  Increased constitutive c-Jun N-terminal kinase signaling in mice lacking glutathione S-transferase Pi.

Authors:  Robert Elsby; Neil R Kitteringham; Christopher E Goldring; Cerys A Lovatt; Mark Chamberlain; Colin J Henderson; C Roland Wolf; B Kevin Park
Journal:  J Biol Chem       Date:  2003-03-19       Impact factor: 5.157

Review 8.  Pathogenic role of glial cells in Parkinson's disease.

Authors:  Peter Teismann; Kim Tieu; Oren Cohen; Dong-Kug Choi; Du Chu Wu; Daniel Marks; Miquel Vila; Vernice Jackson-Lewis; Serge Przedborski
Journal:  Mov Disord       Date:  2003-02       Impact factor: 10.338

9.  Developmental changes in the cellular distribution of glutathione and glutathione S-transferases in the murine nervous system.

Authors:  C M Beiswanger; M H Diegmann; R F Novak; M A Philbert; T L Graessle; K R Reuhl; H E Lowndes
Journal:  Neurotoxicology       Date:  1995       Impact factor: 4.294

10.  Overexpression of Bcl-2 with herpes simplex virus vectors protects CNS neurons against neurological insults in vitro and in vivo.

Authors:  M S Lawrence; D Y Ho; G H Sun; G K Steinberg; R M Sapolsky
Journal:  J Neurosci       Date:  1996-01-15       Impact factor: 6.167

View more
  14 in total

1.  Glutathione S-transferase pi mediates MPTP-induced c-Jun N-terminal kinase activation in the nigrostriatal pathway.

Authors:  Margarida Castro-Caldas; Andreia Neves Carvalho; Elsa Rodrigues; Colin Henderson; C Roland Wolf; Maria João Gama
Journal:  Mol Neurobiol       Date:  2012-04-27       Impact factor: 5.590

2.  Tauroursodeoxycholic Acid Improves Motor Symptoms in a Mouse Model of Parkinson's Disease.

Authors:  Alexandra Isabel Rosa; Sara Duarte-Silva; Anabela Silva-Fernandes; Maria João Nunes; Andreia Neves Carvalho; Elsa Rodrigues; Maria João Gama; Cecília Maria Pereira Rodrigues; Patrícia Maciel; Margarida Castro-Caldas
Journal:  Mol Neurobiol       Date:  2018-04-12       Impact factor: 5.590

Review 3.  S-glutathionylation: from molecular mechanisms to health outcomes.

Authors:  Ying Xiong; Joachim D Uys; Kenneth D Tew; Danyelle M Townsend
Journal:  Antioxid Redox Signal       Date:  2011-05-25       Impact factor: 8.401

4.  Cocaine-induced adaptations in cellular redox balance contributes to enduring behavioral plasticity.

Authors:  Joachim D Uys; Lori Knackstedt; Phelipe Hurt; Kenneth D Tew; Yefim Manevich; Steven Hutchens; Danyelle M Townsend; Peter W Kalivas
Journal:  Neuropsychopharmacology       Date:  2011-07-27       Impact factor: 7.853

5.  Myelinating Glia-Specific Deletion of Fbxo7 in Mice Triggers Axonal Degeneration in the Central Nervous System Together with Peripheral Neuropathy.

Authors:  Sabitha Joseph; Siv Vingill; Olaf Jahn; Robert Fledrich; Hauke B Werner; Istvan Katona; Wiebke Möbius; Mišo Mitkovski; Yuhao Huang; Joachim Weis; Michael W Sereda; Jörg B Schulz; Klaus-Armin Nave; Judith Stegmüller
Journal:  J Neurosci       Date:  2019-05-13       Impact factor: 6.167

Review 6.  Glutathione metabolism and Parkinson's disease.

Authors:  Michelle Smeyne; Richard Jay Smeyne
Journal:  Free Radic Biol Med       Date:  2013-05-08       Impact factor: 7.376

7.  Tauroursodeoxycholic acid prevents MPTP-induced dopaminergic cell death in a mouse model of Parkinson's disease.

Authors:  M Castro-Caldas; A Neves Carvalho; E Rodrigues; C J Henderson; C R Wolf; C M P Rodrigues; M J Gama
Journal:  Mol Neurobiol       Date:  2012-07-08       Impact factor: 5.590

8.  Ubiquitin-proteasome system impairment and MPTP-induced oxidative stress in the brain of C57BL/6 wild-type and GSTP knockout mice.

Authors:  Andreia Neves Carvalho; Carla Marques; Elsa Rodrigues; Colin J Henderson; C Roland Wolf; Paulo Pereira; Maria João Gama
Journal:  Mol Neurobiol       Date:  2012-11-06       Impact factor: 5.590

9.  Discovery of a Necroptosis Inhibitor Improving Dopaminergic Neuronal Loss after MPTP Exposure in Mice.

Authors:  Sara R Oliveira; Pedro A Dionísio; Maria M Gaspar; Maria B T Ferreira; Catarina A B Rodrigues; Rita G Pereira; Mónica S Estevão; Maria J Perry; Rui Moreira; Carlos A M Afonso; Joana D Amaral; Cecília M P Rodrigues
Journal:  Int J Mol Sci       Date:  2021-05-18       Impact factor: 5.923

10.  Exercise does not protect against MPTP-induced neurotoxicity in BDNF haploinsufficient mice.

Authors:  Kim M Gerecke; Yun Jiao; Viswajeeth Pagala; Richard J Smeyne
Journal:  PLoS One       Date:  2012-08-17       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.